Phenogen Sciences, the U.S. subsidiary of Australia-based Genetic Technologies Limited (Nasdaq: GENE), recently presented study results demonstrating that BREVAGen™, a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE